Efficacy of laryngectomy alone for treatment of locally advanced laryngeal cancer: A stage‐ and subsite‐specific survival analysis

Efficacy of laryngectomy alone for treatment of locally advanced laryngeal cancer: A stage‐ and... KeypointsPost operative radiotherapy (PORT) is commonly used in advanced stage larynx cancer.Patients with T3 primary tumors, N0 nodal disease, glottic subsite did not derive survival benefit when treated with PORT.Patients with T4a primary, N1 nodal disease, supraglottic subsite derived survival benefit with PORT.INTRODUCTIONApproximately 13 000 patients are diagnosed with laryngeal cancer each year, and 85‐95% of these tumours are squamous cell carcinomas (SCCs). The majority of patients with laryngeal cancer present with advanced stage disease, most of which is locally advanced. Advanced stage laryngeal cancer has a poor prognosis, carrying a five‐year survival rate of 39%‐60% independent of treatment modality.Advanced stage laryngeal cancer can be treated with surgery with or without adjuvant therapy or primary chemoradiation with similar overall long‐term survival outcomes. However, recent literature suggests that primary surgery may be more effective than chemoradiotherapy for specific subgroups of patients, such as those with T4a or supraglottic primaries, or N0 nodal disease. The gold‐standard surgical management for locally advanced disease is total laryngectomy and neck dissection although some T3 laryngeal tumours can be effectively managed with partial laryngectomy. The high efficacy of surgery for laryngeal cancer may be explained by the wide surgical margins inherent to total laryngectomy and the anatomic http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical Otolaryngology Wiley

Efficacy of laryngectomy alone for treatment of locally advanced laryngeal cancer: A stage‐ and subsite‐specific survival analysis

Loading next page...
 
/lp/wiley/efficacy-of-laryngectomy-alone-for-treatment-of-locally-advanced-Y6so0Yoja2
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
© 2018 John Wiley & Sons Ltd
ISSN
1749-4478
eISSN
1749-4486
D.O.I.
10.1111/coa.13018
Publisher site
See Article on Publisher Site

Abstract

KeypointsPost operative radiotherapy (PORT) is commonly used in advanced stage larynx cancer.Patients with T3 primary tumors, N0 nodal disease, glottic subsite did not derive survival benefit when treated with PORT.Patients with T4a primary, N1 nodal disease, supraglottic subsite derived survival benefit with PORT.INTRODUCTIONApproximately 13 000 patients are diagnosed with laryngeal cancer each year, and 85‐95% of these tumours are squamous cell carcinomas (SCCs). The majority of patients with laryngeal cancer present with advanced stage disease, most of which is locally advanced. Advanced stage laryngeal cancer has a poor prognosis, carrying a five‐year survival rate of 39%‐60% independent of treatment modality.Advanced stage laryngeal cancer can be treated with surgery with or without adjuvant therapy or primary chemoradiation with similar overall long‐term survival outcomes. However, recent literature suggests that primary surgery may be more effective than chemoradiotherapy for specific subgroups of patients, such as those with T4a or supraglottic primaries, or N0 nodal disease. The gold‐standard surgical management for locally advanced disease is total laryngectomy and neck dissection although some T3 laryngeal tumours can be effectively managed with partial laryngectomy. The high efficacy of surgery for laryngeal cancer may be explained by the wide surgical margins inherent to total laryngectomy and the anatomic

Journal

Clinical OtolaryngologyWiley

Published: Jan 1, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off